www.worldpharmaceuticals.net
News, views and contacts from the global World Pharmaceuticals industry
25 January 2022
Industry News

Analytical Service Leaders in Biopharmaceutical and Gene Therapy Development Unify Operations and Re-brand as ProtaGene
Heilbronn & Heidelberg, Germany and Boston, USA – January 12, 2022: Following the announced merger in July 2021, Protagen Protein Services GmbH, BioAnalytix, Inc., and GeneWerk GmbH today announced their unified operations and re-brand as ProtaGene, a world-leading CRO partner for the biopharmaceutical and cell & gene therapy industries.

Wheeler Bio Announces $14M Seed Round To Expand Access To Portable CMC™
OKLAHOMA CITY, OK, January 4, 2022 – (BUSINESS WIRE) – Wheeler Bio, a biomanufacturing company built to accelerate the translation of therapeutic innovation into clinical impact, announced today the closing of a $14M Seed financing round. The round was co-led by Echo Investment Capital and Alloy Therapeutics, with participation from Floating Point and Presbyterian Health Foundation.

Watertown, MA (USA) – November 15, 2021
Arranta Bio Announces Completion of Sale of Florida Site and Progress on $150M Investment Plan to Expand Development and Commercial Manufacturing Services

You are receiving this email because you are either a valued subscriber to World Pharmaceutical Frontiers or have signed up via a partner web site. Your email address has not been, and will not be, given to third parties.

Global Trade Media, a trading division of SPG Media Ltd | Registered office: John Carpenter House, John Carpenter Street, London, EC4Y 0AN | Registered in England No. 01155599.